Volume 2 • Issue 2 • 2022 • Summer 2022

Original Research

The United States Food and Drug Administration’s Innovative Alternative Tools to Evaluate Good Clinical Practice During the COVID-19 Public Health Emergency

Kassa Ayalew , Jenn Sellers , Phillip D. Kronstein , Laurie Muldowney , Emily Gebbia , Jean Mulinde and David Burrow

2023-02-10 Volume 2 • Issue 2 • 2022 • Summer 2022

Consensus Papers

What and how will the Risk Based Approach to Monitoring change? Survey of RBM in medical institutions

Kiyoko Adachi , Mayumi Shirase , Yukie Kimura , Yasutoshi Kuboki and Takayuki Yoshino

2022-12-16 Volume 2 • Issue 2 • 2022 • Summer 2022